@Article{Nakashima2008,
journal="Archives of Medical Science",
issn="1734-1922",
volume="4",
number="2",
year="2008",
title="Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis \– a case report",
abstract="This paper reports two cases showing transient thyrotoxicosis caused by prolonged use of gonadotropin-releasing hormone (GnRH) agonist. Case 1,  a 31-year-old woman, was administered GnRH-agonist (leuprorelin acetate) for treatment of endometriosis. After four months she showed thyroid dysfunction. Case 2, a 43-year-old woman, who was previously diagnosed with chronic thyroiditis, was treated with GnRH-agonist (nafarelin acetate) for her endometriosis. Five months later, her thyroid functions worsened. After discontinuation of the GnRH-agonist, thyroid function of both cases recovered. In selected patients, who are on GnRH-agonist, attention to thyroid function is important.",
author="Nakashima, Akira
and Nakagawa, Koji
and Ohgi, Shirei
and Horikawa, Takashi
and Kamura, Toshiharu
and Saito, Hidekazu",
pages="200--203",
url="https://www.termedia.pl/Case-report-Transient-thyrotoxicosis-following-prolonged-use-of-gonadotropin-releasing-hormone-agonist-in-women-with-endometriosis-8211-a-case-report,19,10674,1,1.html"
}